Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02034123 |
| Title | Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
| GSK Investigational Site | Columbus | Ohio | 43210 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Villejuif cedex | 94805 | France | Details | ||
| GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28034 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
| GSK Investigational Site | Málaga | 29010 | Spain | Details |